Loading...
Bedaquiline versus placebo for management of multiple drug-resistant tuberculosis: A systematic review
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is associated with significant morbidity and mortality. Bedaquiline is the first drug approved for treating MDR-TB. OBJECTIVES: We performed a systematic review and meta-analysis to summarize the totality of all available evidence on the efficacy...
Na minha lista:
| Udgivet i: | Indian J Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825437/ https://ncbi.nlm.nih.gov/pubmed/27127322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.178839 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|